| TBCRC 048: phase II study of olaparib for metastatic breast cancer and mutations in homologous recombination-related genes NM Tung, ME Robson, S Ventz, CA Santa-Maria, R Nanda, PK Marcom, ... Journal of Clinical Oncology 38 (36), 4274-4282, 2020 | 318 | 2020 |
| TBCRC 031: randomized phase II study of neoadjuvant cisplatin versus doxorubicin-cyclophosphamide in germline BRCA carriers with HER2-negative breast cancer (the INFORM trial) N Tung, B Arun, MR Hacker, E Hofstatter, DL Toppmeyer, SJ Isakoff, ... Journal of Clinical Oncology 38 (14), 1539, 2020 | 119 | 2020 |
| TBCRC 048: A phase II study of olaparib monotherapy in metastatic breast cancer patients with germline or somatic mutations in DNA damage response (DDR) pathway genes (Olaparib … NM Tung, ME Robson, S Ventz, CA Santa-Maria, PK Marcom, R Nanda, ... Journal of Clinical Oncology 38 (15_suppl), 1002-1002, 2020 | 57 | 2020 |
| Targeted BRCA1/2 population screening among Ashkenazi Jewish individuals using a web-enabled medical model: an observational cohort study KM Morgan, JG Hamilton, H Symecko, D Kamara, C Jenkins, J Lester, ... Genetics in Medicine 24 (3), 564-575, 2022 | 9 | 2022 |
| Comparison of up-front cash cards and checks as incentives for participation in a clinician survey: a study within a trial LE Pace, YS Lee, N Tung, JG Hamilton, C Gabriel, SC Raja, C Jenkins, ... BMC Medical Research Methodology 20 (1), 1-7, 2020 | 6 | 2020 |
| Analysis of real-world (RW) data for metastatic breast cancer (mBC) patients (pts) with somatic BRCA1/2 (sBRCA) or other homologous recombination (HR … F Batalini, R Madison, DC Pavlick, E Sokol, T Snow, A Sondhi, ... Journal of Clinical Oncology 39 (15_suppl), 10512-10512, 2021 | 3 | 2021 |
| Early results from the BRCA Founder Outreach (BFOR) Study: Population genetic screening using a medical model. K Morgan, C Gabriel, H Symecko, J Lester, J Levin, D Kamara, ... Journal of Clinical Oncology 37 (15_suppl), 1578-1578, 2019 | 3 | 2019 |
| Challenges and Opportunities in Engaging Primary Care Providers in BRCA Testing: Results from the BFOR Study LE Pace, N Tung, YS Lee, JG Hamilton, C Gabriel, A Revette, S Raja, ... Journal of General Internal Medicine, 1-8, 2021 | 2 | 2021 |
| Detection of homologous recombination deficiency (HRD) using a novel genomic and epigenomic liquid biopsy assay in patients with breast cancer. C Barbacioru, J Yen, D Tolkunov, P Safabakhsh, H Wang, A Gross, ... Journal of Clinical Oncology 41 (16_suppl), 556-556, 2023 | 1 | 2023 |
| The BRCA founder outreach study: Initial results of a digital health model. K Morgan, H Symecko, D Kamara, C Jenkins, J Levin, J Lester, ... Journal of Clinical Oncology 38 (15_suppl), 2007-2007, 2020 | 1 | 2020 |
| Characterization of whole genome duplication in a genomic cohort of over 14000 cell free DNA samples A Gross, H Wang, D Tolkunov, C Jenkins, S Wienke, C Barbacioru, ... Cancer Research 84 (6_Supplement), 406-406, 2024 | | 2024 |
| BRCA1 promoter methylation in sporadic breast cancer patients detected by liquid biopsy J Yen, S Chen, C Jenkins, LM Drusbosky, B Overstreet, J Zhao, Y Fu, ... chemotherapy 1 (2), 3, 2023 | | 2023 |
| FAMILIAL IMPACT OF POPULATION-BASED BRCA1/2 GENETIC SCREENING: INITIAL RESULTS FROM THE BRCA FOUNDER OUTREACH (BFOR) STUDY JG Hamilton, K Morgan, J Levin, H Symecko, J Lester, C Jenkins, ... ANNALS OF BEHAVIORAL MEDICINE 55, S591-S591, 2021 | | 2021 |
| A randomized study of cash cards versus checks as clinician survey incentives LE Pace, YS Lee, N Tung, JG Hamilton, C Gabriel, SC Raja, C Jenkins, ... | | 2020 |
